Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).
Pancreatic adenocarcinoma continues to be a leading cause of cancer death in the Western world and is amongst the leading gastrointestinal cancers. The incidence of pancreatic cancer has been stable or slowly rising in the past few decades. Overall the prognosis is poor with 5-year survival rates still under 5%. Therefore early detection and accurate staging of these tumors is crucial for optimal treatment.
Francis
Isaac R
IR
University of Michigan Hospitals, Ann Arbor, MI 48109-0030, USA. ifrancis@umich.edu
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000000981:diagnostic imaging; D003287:Contrast Media; D003937:Diagnosis, Differential; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed / Q000379:methods*
D003287:Contrast Media